Can type 2 diabetes go into remission?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
Type 2 diabetes can go into remission. The 2021 international consensus defines remission as an HbA1c below 6.5 percent that persists for at least three months without glucose lowering medication. In the DiRECT trial, 46 percent of people in a structured weight management program were in remission at 12 months, and 36 percent at 24 months.
Remission of type 2 diabetes is a defined clinical state, not a marketing phrase. An expert group convened by the ADA, EASD, Diabetes UK and the Endocrine Society defined it in 2021 as "a return of HbA1c to less than 6.5 percent that occurs spontaneously or following an intervention and that persists for at least 3 months in the absence of usual glucose-lowering pharmacotherapy". The word cure was deliberately not used.
What the DiRECT trial showed
DiRECT randomized primary care practices in Scotland and England. Participants stopped their diabetes medications and used a formula diet of 825 to 853 kcal a day for three to five months, then reintroduced food with structured support. At 12 months, 46 percent of the intervention group were in remission compared with 4 percent of controls. Among those who lost 15 kg or more, 86 percent achieved remission. At 24 months, 36 percent of the intervention group remained in remission versus 3 percent of controls.
How durable is remission
Remission tracks weight. In the five year DiRECT extension published in 2024, 13 percent of intervention participants with data at five years were still in remission, and those who stayed in remission had maintained an average weight loss of 8.9 kg. That is a smaller number than the headline, and it is the honest one. Remission is a state that has to be held, in the same way blood pressure control has to be held.
| Time point | In remission, intervention | In remission, control |
|---|---|---|
| 12 months | 46 percent | 4 percent |
| 24 months | 36 percent | 3 percent |
| 5 years | 13 percent of those with data | Not applicable, extension design |
Who is most likely to achieve it
The people most likely to reach remission are those diagnosed recently, those with higher body weight to lose, and those not yet on insulin. DiRECT enrolled adults aged 20 to 65 diagnosed within the previous six years, with a BMI of 27 to 45, and not on insulin. Longer standing diabetes reflects more beta cell loss, which is the part weight loss cannot fully undo. Metabolic surgery achieves remission in a substantial proportion of people as well, and is the option with the largest and most durable weight loss.
If remission is your goal, ask three questions at your next visit: how long have I had diabetes, am I on medications that need to be reduced as weight falls, and what weight loss target are we aiming for. Then ask for HbA1c to be rechecked no sooner than three months after glucose lowering medication is stopped, which is what the consensus definition requires, and at least yearly after that.
The clinical detail
The 2021 consensus recommends HbA1c below 48 mmol/mol (6.5 percent) measured at least three months after stopping glucose lowering pharmacotherapy and at least three months after the start of the intervention, with repeat testing at least yearly to confirm continuing remission. Where HbA1c is unreliable, a fasting plasma glucose below 126 mg/dL or an estimated A1C below 6.5 percent derived from continuous glucose monitoring may be substituted.
Remission does not remove the need for continued surveillance. Retinopathy screening, kidney function, blood pressure and lipid management continue on the usual schedule, because microvascular and cardiovascular risk does not return to that of a person who never had diabetes.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia. DOI 10.1007/s00125-021-05542-z
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. PMID 29221645
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of DiRECT. The Lancet Diabetes and Endocrinology. PMID 30852132
- 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT): an extension study. The Lancet Diabetes and Endocrinology. PMID 38423026
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.